leisure time -WSS

leisure time

author：hotspot 2025-09-27 10:05:16 - browse：13

a photo of the federal trade commission building — Alex Brandon/AP

The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider.

Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player, Novant, even more powerful. And even though smaller deals like this get less attention than huge, 100-plus hospital mergers, they can still drive up people’s insurance premiums and medical bills.

In this case, Novant, a nonprofit system with $7.6 billion in 2022 revenue, plans to buy two hospitals in the same county from the for-profit chain Community Health Systems for $320 million. The two hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only about a 25-minute drive from one another. A Novant spokesperson called the FTC’s position flawed and said the system will pursue available legal responses. CHS spokesperson Tomi Galin wrote in an email that a judge will make the final determination on whether the transaction can proceed and thanked staff for continuing to deliver quality care during the regulatory process.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Cord blood banking comes at a high cost to babies

WSS

The nurse manager staffing crisis is hurting patients

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Fauci’s Covid grilling leads GOP to weigh foreign research rules

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

HIV drugs protect against transmission, even in unprotected sex

focus

leisure time

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The SUPPORT Act is critical to fighting the opioid crisis

As demand for Covid shots wanes, Moderna seeks its next success

As JPM 2024 winds down, some health tech firms project optimism

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

In age of alternative facts, a scholarly course on calling out crap

Heart disease and mental health: A look at cardiac psychology

Medicare details structure of new drug price negotiation program

ASCO: AstraZeneca says CAR

Wikipedia

New England Journal of Medicine addresses racist history, slavery

Designating disabled people as health disparity population is crucial

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Innovation in antibiotics is ailing. 'Brain drain' may kill it

ASCO: AstraZeneca says CAR

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

leisure time

focus

entertainment

Wikipedia